Back
Corporate News
Kimia Biosciences to review Q2 and half-year financials at November board meeting
04-Nov-2026, 02:39
Kimia Biosciences Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for equity shares of the company for designated persons and their immediate relatives has been closed from October 1, 2026, until 48 hours after the financial results are declared.